Big Pharma Reaps Billions
From Swine Flu Fearmongering
Pharmaceutical corporations are reaping obscene profits as a result
of the media fearmongering behind the swine flu outbreak, despite
the fact that the H1N1 virus has killed far less people that the
According to a new ABC
News report out today entitled, Drugmakers, Doctors Rake in
Billions Battling H1N1 Flu, Drug companies have sold $1.5
billion worth of swine flu shots, in addition to the $1 billion
for seasonal flu they booked earlier this year. These inoculations
are part of a much wider and rapidly growing $20 billion global
U.S. taxpayers have footed the bill for 250 million swine flu
vaccines that the government has ordered so far, with Sanofi-Pasteur,
Glaxo Smith Kline and Novartis taking most of the profits.
Doctors are also being paid for each vaccination they administer,
introducing a financial motive for them to push the inoculation
despite fears about the dangerous additives contained in the shot.
Companies outside of the medical industry, such as supermarkets
who are offering the flu shots as well as delivery companies like
UPS are also enjoying the windfall from a mass propaganda campaign
that is brow-beating Americans into taking the shot despite the
fact that the swine flu virus has proven far less deadly than
the regular flu virus.
The fact that big pharma has more than doubled its usual income
from flu vaccines illustrates the motivation behind why the pharmaceutical
lobby has been busy fearmongering about swine flu since it first
emerged in Mexico earlier this year.
The establishment media has embarked upon an agenda to smear
rising public opposition and suspicion towards the vaccination
campaign as the product of the anti-vaccine lobby,
attempting to attach a sense of malevolence to what amounts to
a mere handful of health professionals warning about the dangers
of the shot in comparison with the behemoth pharmaceutical lobby
that is pushing it.
As we reported earlier, the pharmaceutical lobby is an industry
that has no less than 1,274 registered lobbyists in Washington
D.C. alone and spent around $900 million on lobbying between 1998
and 2005, more than any other industry. Big pharma lobbied on
at least 1,600 pieces of legislation between 1998 and 2004.
As a money making scheme, the swine flu scam has proven immensely
profitable for big pharma during a climate where they would normally
be struggling to stay afloat, in the middle of an economic recession.
full list of h1n1 vaccine ingredients, alerts and warnings.
Reference Source 183
October 14, 2009